by Kirsteen Mackay | Dec 12, 2020 | RNS Responses
With cannabis legalization ramping up across Canada and the US, pot stocks have been garnering interest again. Over the past five years, US states have been gradually decriminalizing cannabis and now it’s widely accepted throughout North America and Canada....
by Mark Sheridan | Dec 11, 2020 | Features
LOBE SCIENCES (CSE:LOBE | OTC:GTSIF) Collaboration between under-the-radar R&D firm and Miami medical school could unlock the secret to solving the mental health crisis… To understand one of the most exciting advantages under-the-radar Canadian...
by Mark Sheridan | Nov 30, 2020 | RNS Responses
Tiziana Life Sciences (LSE:TILS | NASDAQ:TLSA) If nothing else, the Covid stock bubble has shined a light on otherwise largely ignored AIM-listed British life sciences and biotech firms. And the steady decline of pure Covid testing plays has thrown up a set of...
by Kirsteen Mackay | Nov 21, 2020 | RNS Responses
Clean energy has been the talk of the town in recent years, but since 2020 ground to a halt the Covid-19 pandemic is hijacking the headlines. Now, that’s all about to change. With President-elect Joe Biden due to take office next month, it marks a new beginning for...
by Mark Sheridan | Nov 19, 2020 | Market Flashes
Open Orphan (LSE:ORPH) Open Orphan subsidiary hVIVO has been selected to lead a highly-respected group to create international standards for drugs used in human challenge trials. The Dublin-headquartered contract research firm will lead a consortium to generate...
